DE3876558D1 - Hyposensibilisierend wirksame substanz. - Google Patents

Hyposensibilisierend wirksame substanz.

Info

Publication number
DE3876558D1
DE3876558D1 DE8888308370T DE3876558T DE3876558D1 DE 3876558 D1 DE3876558 D1 DE 3876558D1 DE 8888308370 T DE8888308370 T DE 8888308370T DE 3876558 T DE3876558 T DE 3876558T DE 3876558 D1 DE3876558 D1 DE 3876558D1
Authority
DE
Germany
Prior art keywords
hyposensibilizing
effective substance
substance
effective
hyposensibilizing effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888308370T
Other languages
English (en)
Other versions
DE3876558T2 (de
Inventor
Tyoku Matsuhashi
Mitsuko Usui
Masakazu Mitsuhashi
Shunsaku Ando
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of DE3876558D1 publication Critical patent/DE3876558D1/de
Application granted granted Critical
Publication of DE3876558T2 publication Critical patent/DE3876558T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8888308370T 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz. Expired - Fee Related DE3876558T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22878187 1987-09-12
JP63184487A JP2594123B2 (ja) 1987-09-12 1988-07-26 減感作剤

Publications (2)

Publication Number Publication Date
DE3876558D1 true DE3876558D1 (de) 1993-01-21
DE3876558T2 DE3876558T2 (de) 1993-04-29

Family

ID=26502527

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8888308370T Expired - Fee Related DE3876558T2 (de) 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz.
DE198888308370T Pending DE308147T1 (de) 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198888308370T Pending DE308147T1 (de) 1987-09-12 1988-09-09 Hyposensibilisierend wirksame substanz.

Country Status (6)

Country Link
US (1) US4939239A (de)
EP (1) EP0308147B1 (de)
JP (1) JP2594123B2 (de)
KR (2) KR970010543B1 (de)
CA (1) CA1333256C (de)
DE (2) DE3876558T2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2838800B2 (ja) * 1989-09-02 1998-12-16 株式会社林原生物化学研究所 減感作剤
US6982326B1 (en) * 1991-07-12 2006-01-03 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from Japanese cedar pollen
US6090386A (en) * 1991-07-12 2000-07-18 Griffith; Irwin J. T cell peptides of the CRX JII allergen
CA2112913A1 (en) * 1991-07-12 1993-01-21 Irwin J. Griffith Allergenic proteins and peptides from japanese cedar pollen
JP3149033B2 (ja) * 1991-10-30 2001-03-26 アサヒビール株式会社 ダニ主要アレルゲンＤｅｒ ｆ ＩＩ中のペプチド
EP0659214A1 (de) * 1992-09-01 1995-06-28 Immulogic Pharmaceutical Corporation Allergene Proteine und Peptide aus Pollen vom japanischen Zeder.
DE69418433T2 (de) * 1993-11-05 1999-10-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Allergenisches Polypeptid von japanischen Zederpollen und diese kodierende DNA
JP3512452B2 (ja) * 1993-12-21 2004-03-29 株式会社林原生物化学研究所 ポリペプチドとその製造方法並びに用途
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
JPH07188291A (ja) * 1993-12-27 1995-07-25 Hayashibara Biochem Lab Inc 蛋白質とその製造方法並びに用途
US5912000A (en) * 1994-09-23 1999-06-15 Zonagen, Inc. Chitosan induced immunopotentiation
ATE223235T1 (de) * 1994-09-23 2002-09-15 Zonagen Inc Chitosan induzierte verstärkung
US8021667B2 (en) 1994-11-16 2011-09-20 Macfarlane Burnet Institute For Medical Research And Public Health Ltd Compositions for immunotherapy and uses thereof
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
JP4669930B2 (ja) 1997-09-29 2011-04-13 マクファーレン バーネット インスティテュート フォー メディカル リサーチ アンド パブリック ヘルス リミテッド 抗原に対する細胞媒介性免疫応答を誘導するための免疫調節組成物
IL145851A0 (en) * 1999-04-15 2002-07-25 Childrens Medical Center Osteopontin-derived chemotactic and inhivitory agents and uses therefor
AU4431600A (en) * 1999-05-11 2000-11-21 Kyowa Hakko Kogyo Co. Ltd. Novel pollen antigen
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
US20050048614A1 (en) * 2000-06-13 2005-03-03 Children's Medical Center Corporation Biosynthetic oncolytic molecules and uses therefor
KR100425253B1 (ko) * 2001-04-18 2004-03-30 주식회사 현대시스콤 무선통신 시스템에서의 순방향 패킷 송수신 방법
JP4180258B2 (ja) * 2001-08-06 2008-11-12 西川ゴム工業株式会社 ＩｇＥ抗体抑制剤および食品
AU2002359721A1 (en) * 2001-12-19 2003-07-09 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
DE10209821A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
EP1356826A1 (de) * 2002-04-22 2003-10-29 BIOMAY Produktions- und Handels- Aktiengesellschaft Mikropartikel die Kohlenhydratkugeln enthalten an welche ein Allergen kovalent gebunden sind
JP2004099511A (ja) * 2002-09-09 2004-04-02 Japan Research & Development Association For New Functional Foods 免疫抑制剤および食品
IL166506A0 (en) * 2002-09-11 2006-01-15 Fresenius Kabi De Gmbh Hasylated polypeptides especially hasylated erythropoietin
DE10242076A1 (de) * 2002-09-11 2004-03-25 Fresenius Kabi Deutschland Gmbh HAS-Allergen-Konjugate
US7923209B2 (en) 2003-03-14 2011-04-12 Anergis, S.A. Allergen peptide fragments and use thereof
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
SG145746A1 (en) * 2003-08-08 2008-09-29 Fresenius Kabi De Gmbh Conjugates of hydroxyalkyl starch and g-csf
ES2390885T3 (es) * 2004-03-11 2012-11-19 Fresenius Kabi Deutschland Gmbh Conjugados de hidroxialquilalmidón y una proteína
CN1946742A (zh) * 2004-03-11 2007-04-11 弗雷泽纽斯卡比德国有限公司 通过还原氨基化制备的羟烷基淀粉和蛋白质的偶联物
KR20070110902A (ko) * 2005-03-11 2007-11-20 프레제니우스 카비 도이치란트 게엠베하 비활성 출발 물질로부터 생물활성 당단백질의 생산
EP1762250A1 (de) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Konjugate welche durch chemische Ligation zwischen Hydroxyalkylstärken und aktiven Substanzen mit Bildung eines Thiazolidin-Ringes entstehen
WO2007044396A2 (en) * 2005-10-04 2007-04-19 The Research Foundation Of State University Of New York Fibronectin polypeptides and methods of use
CN102876627B (zh) * 2006-03-23 2014-10-22 西澳大利亚大学 肌腱细胞培养基及其培养方法和应用
US9095603B2 (en) 2006-04-05 2015-08-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Anti-allergy compositions
WO2008128304A1 (en) * 2007-04-24 2008-10-30 The University Of Western Australia Tenocyte containing bioscaffolds and treatment using the same
WO2008157483A2 (en) * 2007-06-14 2008-12-24 The Research Foundation Of State University Of New York Polypeptides and methods of use
US8466140B2 (en) * 2007-09-10 2013-06-18 University Of Massachusetts Mitochondria-targeted anti-tumor agents
JP5497006B2 (ja) 2008-04-14 2014-05-21 ザ ジェネラル ホスピタル コーポレイション 膵管腺癌の検出および治療のためのプレクチン−１標的化剤
EP2123261A1 (de) * 2008-05-20 2009-11-25 Stallergenes S.A. Speichelklebende Partikelformulierung zur Induzierung von antigenspezifischer Immuntoleranz
US9989533B2 (en) 2009-05-28 2018-06-05 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Anti-TNF induced apoptosis (ATIA) diagnostic markers and therapies
JP5931449B2 (ja) * 2012-01-11 2016-06-08 日東電工株式会社 医薬組成物及びその製造方法
AU2012392291B2 (en) * 2012-10-19 2017-12-07 Hal Allergy Holding B.V. Compositions for immunotherapy
CA2979523A1 (en) 2015-05-01 2016-11-10 Nitto Denko Corporation Allergy vaccine composition
AU2017343752B2 (en) 2016-10-14 2021-12-16 Neomatrix Therapeutics, Inc Peptides derived from fibronectin with improved bioactivity and reduced susceptibility to neutrophil elastase degradation
US10729741B2 (en) 2017-03-27 2020-08-04 Neomatrix Therapeutics Inc. Methods of treating burns with i.v. cP12 in a window from 2 to 6 hours after injury

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4185090A (en) * 1972-02-02 1980-01-22 Abbott Laboratories Chemically modified endotoxin immunizing agent
EP0058021A3 (de) * 1981-02-06 1982-10-27 Beecham Group Plc Pharmazeutische Präparate

Also Published As

Publication number Publication date
EP0308147A1 (de) 1989-03-22
KR100234792B1 (ko) 1999-12-15
KR890004717A (ko) 1989-05-09
KR19980083429A (ko) 1998-12-05
JP2594123B2 (ja) 1997-03-26
CA1333256C (en) 1994-11-29
US4939239A (en) 1990-07-03
EP0308147B1 (de) 1992-12-09
DE3876558T2 (de) 1993-04-29
KR970010543B1 (ko) 1997-06-28
JPH01156926A (ja) 1989-06-20
DE308147T1 (de) 1990-03-01

Similar Documents

Publication Publication Date Title
DE3876558D1 (de) Hyposensibilisierend wirksame substanz.
DE3862564D1 (de) Erdanker.
FI77952B (fi) Ljusbaogsrelae.
DE3867976D1 (de) Polymergebundene antioxydationsmittel.
DE3883705D1 (de) Alkenylbicyclohexane.
DE3785663D1 (de) Loetgeraet.
DE3876304D1 (de) Polysilacylobutasilazane.
DE3870513D1 (de) Tennisball.
FI880671A0 (fi) Laongspalt-valspress.
DE3888991D1 (de) Aminokohlenwasserstoff-substituierte Ketoximosilane.
FI77055B (fi) Vaermegradient-inkubator.
FI884750A0 (fi) Shampokompositioner.
DE3862309D1 (de) Aminomethyltetrahydrofurane.
FI86994B (fi) Korrosionsfasta vismut innehaollande zirkoniumlegeringar.
ES2023228B3 (es) Ciclopropancarboxamidas.
DE3860710D1 (de) Exklusiv-oder-schaltung.
DE3860307D1 (de) 2-aminomethyltetrahydrofurane.
DE3866770D1 (de) Gerbstoff.
DE3867805D1 (de) Paraocclusaler loeffel.
DE3873615D1 (de) Polycyanoarylthioether.
FI870073A (fi) En placeringsstruktur foer passagerarhytter.
FI883921A (fi) Expansionskropp.
DE3870799D1 (de) Orthese.
DE3875119D1 (de) Sportschuh.
FI890870A0 (fi) Hjaertklaffprotes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee